Asset Acquisitions and Disposals::PROPOSED ACQUISITION OF 58% OF THE SHARE CAPITAL IN ARDENCE PHARMA SDN BHD OVER 3 TRANCHES
Issuer & Securities
Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No
Announcement Details
Announcement Title
Asset Acquisitions and Disposals
Date &Time of Broadcast
17-Oct-2023 17:13:52
Status
New
Announcement Sub Title
PROPOSED ACQUISITION OF 58% OF THE SHARE CAPITAL IN ARDENCE PHARMA SDN BHD OVER 3 TRANCHES
Announcement Reference
SG231017OTHRNWE2
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman and CEO
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached.
This announcement has been reviewed by the Company's Sponsor, SAC Capital Private Limited (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement including the correctness of any statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms Lee Khai Yinn (Tel: +65 6232 3210) at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542.
Attachments
Hyphens - Media Release- Proposed Acquisition of Share Capital in Ardence Pharma Sdn Bhd over 3 Tranches.pdf
Hyphens - Proposed Acquisition of Share Capital in Ardence Pharma Sdn Bhd over 3 Tranches.pdf
Total size =1631K
Related Announcements
Related Announcements